Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Burkitt lymphoma prognostic index may lead to more targeted therapy Next Article
Anti-CD20 therapy for lymphoma tied to worse COVID-19 outcomes »
« Burkitt lymphoma prognostic index may lead to more targeted therapy Next Article
Anti-CD20 therapy for lymphoma tied to worse COVID-19 outcomes »
Related Articles
October 30, 2022
Favipiravir may help patients over 60 years with COVID-19 to recover

May 24, 2017
Letter from the Editor
November 9, 2021
No immunological parameters identified for Down syndrome children
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy